ALB and cancer: In a univariable logistic regression model including prealbumin and albumin deficiency, as well as low UAMA percentile, pretreatment albumin deficiency was shown to be a significant predictor of 3 or more infectious episodes during cancer treatment (p = 0.02) (Table 9).